Transpact Enterprises Ltd
ListedSMEEmerging SME Services · BSE
Incorporated in 2013, Maharashtra-based Transpact Enterprises Limited is a biotechnology startup focused on developing innovative and affordable solutions for specially-abled individuals. The company primarily designs, develops, and distributes the Vestibulator, a therapeutic device created to address vestibular dysfunctions. The Vestibulator is a co-patented technology of Transpact Enterprises and IRCC-IIT Bombay, and the company holds a license from the Society for Innovation and Entrepreneurship, IIT Bombay, to commercialize the product. While the design and customization of the device are handled in-house with the help of advanced software, the manufacturing process is outsourced to third-party vendors. Transpact Enterprises is dedicated to continuous innovation to enhance its offerings and improve the quality of life for its users.
Price Band
₹130
Issue Size
₹1.35 Cr
Lot Size
1000 shares
GMP
—
Est. Listing
₹130
at current GMP
Subscribed
—
Open
26 Aug 2019
Close
28 Aug 2019
Allotment
3 Sep 2019
Refund
4 Sep 2019
Demat Credit
5 Sep 2019
Listing
5 Sep 2019
Last updated 12 days ago
Key Highlights
- •Leading player in the Indian market segment
- •Price band established at ₹130 - ₹130 per equity share
- •Minimum bid lot is 1000 shares
- •Estimated listing target of ₹130 based on current grey market activity